Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Therapeutic options in an era of decreasing antimicrobial susceptibility.

Journal of chemotherapy (Florence, Italy) - 1 Feb 2002

Drlica K, Schmitz F J

Abstract excerpt

Antimicrobial resistance among human pathogens has evolved to the multidrug-resistant phase. Consequently, preserving antimicrobial efficacy is now an important clinical consideration when selecting an agent for therapy. A new, in vitro measure of potency called the mutant prevention concentration (MPC) allows clinicians to select antibacterials on the basis of an agent's ability to restrict the selection of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-Bacterial Agents
Share to Anti-Infective Agents
Share to Clinical Trials as Topic

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Resistance

Share to Fluoroquinolones

Share to Microbial Sensitivity Tests

Share to Mutation

Share to Predictive Value of Tests

Source

Identifiers

PMID: 12003139

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Therapeutic options in an era of decreasing antimicrobial susceptibility.PMID 12003139Read ↗

New concepts in antimicrobial susceptibility testing: the mutant prevention concentration and mutant selection window approach.Semantic proximity Read ↗

The mutant selection window and antimicrobial resistance.Semantic proximity Read ↗

Mutant prevention concentrations of fluoroquinolones for clinical isolates of Streptococcus pneumoniae.Semantic proximity Read ↗

Predicting and preventing antimicrobial resistance utilizing pharmacodynamics: Part I gram positive bacteria.Semantic proximity Read ↗

Restricting the selection of antibiotic-resistant mutant bacteria: measurement and potential use of the mutant selection window.Semantic proximity Read ↗

Antibiotic resistance--what's dosing got to do with it?Semantic proximity Read ↗

A unified anti-mutant dosing strategy.Semantic proximity Read ↗

Mutant selection window hypothesis updated.Semantic proximity Read ↗

Suppression of Emergence of Resistance in Pathogenic Bacteria: Keeping Our Powder Dry, Part 1.Semantic proximity Read ↗

Comparison of minimal inhibitory and mutant prevention drug concentrations of 4 fluoroquinolones against clinical isolates of methicillin-susceptible and -resistant Staphylococcus aureus.Semantic proximity Read ↗

Mutant prevention concentration as a measure of antibiotic potency: studies with clinical isolates of Mycobacterium tuberculosis.Semantic proximity Read ↗

The changing face of antibiotic prescribing: the mutant selection window.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.